Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Formulation exports boost Zydus Cadila's revenues in Q3

This article was originally published in Scrip

Executive Summary

Zydus Cadila has reported a 31% increase in revenues to Rs7.59 billion ($155.5 million) for the third quarter ended December 2008, led by a surge in formulations exports. Net profits rose by 17% to Rs610 million. The profits are after providing for an exchange rate fluctuation loss of Rs110 million on conversion of foreign currency loans during the quarter, as against a gain of Rs60 million during the same period last year. Formulation exports rose by 61%.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts